Patents Assigned to Sucampo AG (USA) Inc.
  • Method for treating ocular hypertension and glaucoma
    Patent number: 8673973
    Abstract: Provided is a method for treating ocular hypertension and glaucoma with reduced side effects such as keratoconjunctive disorders and macular edema, which comprises administering an ophthalmic composition comprising latanoprost as an active ingredient thereof to a subject in need of said treatment, wherein the ophthalmic composition contains substantially no benzalkonium chloride.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: March 18, 2014
    Assignee: Sucampo AG (USA) Inc.
    Inventor: Ryuji Ueno
  • Method for treating ocular hypertension and glaucoma
    Patent number: 7074827
    Abstract: Provided is a method for treating ocular hypertension and glaucoma with reduced side effects such as keratoconjunctive disorders and macular edema, which comprises administering an ophthalmic composition comprising latanoprost as an active ingredient thereof to a subject in need of said treatment, wherein the ophthalmic composition contains substantially no benzalkonium chloride.
    Type: Grant
    Filed: May 6, 2003
    Date of Patent: July 11, 2006
    Assignee: Sucampo AG (USA) Inc.
    Inventor: Ryuji Ueno